Active surveillance of renal masses in von Hippel-Lindau disease: Growth rates and clinical outcome over a median follow-up period of 56 months

Familial Cancer

Volumn 11, Issue 2, 2012, Pages 209-214

  Zhang, Jin ^a   Pan, Jia Hua ^a   Dong, Bai Jun ^a   Xue, Wei ^a   Liu, Dong Ming ^a   Huang, Yi Ran ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Natural history; Renal mass; Von Hippel Lindau disease; Watchful waiting

Indexed keywords

ADULT; ARTICLE; BRAIN HEMORRHAGE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MALE; METASTASIS; NEPHRECTOMY; PANCREAS CYST; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RETINA TUMOR; TUMOR GROWTH; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMANGIOBLASTOMA; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; VON HIPPEL-LINDAU DISEASE;

EID: 84864701997     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9503-5     Document Type: Article

References (24)

1. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151-1163
2. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) Von Hippel-Lindau disease. Lancet 361:2059-2067
3. Latif F, ToryK,Gnarra J et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320
4. Grubb RL III, Choyke PL, Pinto PA, Linehan WM, Walther MM (2005) Management of von Hippel-Lindau associated kidney cancer. Nat Clin Pract Urol 2:248-255
5. Bratslavsky G, Liu JJ, Johnson AD et al (2008) Salvage partial nephrectomy for hereditary renal cancer: Feasibility and outcomes. J Urol 179:67-70
6. Joly D, Méjean A, Corréas JM et al (2011) Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. J Urol 185:2056-2060
7. Walther MM, Choyke PL, Glenn G, Lyne JC, Rayford W, Venzon D, Linehan WM (1999) Renal cancer in families with hereditary renal cancer: Prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161: 1475-1479
8. Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM (2004) The relationship between renal tumor size and metatases in patients with von Hippel-Lindau disease. J Urol 172:63-65
9. Ploussard G, Droupy S, Ferlicot S, Ples R, Rocher L, Richard S, Benoit G (2007) Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology 70:435-439
10. Matin SF, Ahrar K, Wood CG, Daniels M, Jonasch E (2008) Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU 102:940-945
11. Maher ER, Yates JR, Harries R et al (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151-1163
12. Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300:230-235
13. Zhang J, Huang Y, Pan J et al (2008) Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families. J Cancer Res Clin Oncol 134:1211-1218
14. Choyke PL, Walther MM, Zbar B et al (1992) The natural history of renal lesions in von Hippel-Lindau disease: A serial CT study in 28 patients. AJR Am J Roentgenol 159:1229-1234
15. Neumann HP, Bender BU, Berger DP et al (1998) Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160:1248-1254
16. Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G (2010) Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol 184:59-63
17. Steinbach F, Novick AC, Zincke H et al (1995) Treatment of renal cell carcinoma in von Hippel-Lindau disease: A multicenter study. J Urol 153:1812-1816
18. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: Meta-Analysis and review of the world literature. J Urol 175:425-431
19. Kouba E, Smith A, McRackan D, Wallen EM, Pruthi RS (2007) Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 177:466-470
20. Abouassaly R, Lane BR, Novick AC (2008) Active surveillance of renal masses in elderly patients. J Urol 180:505-509
21. Beisland C, HjelleKM,Reister LAR,BostadL (2009)Observation should be considered as an alternative in management of renal masses in older and comorbid patients. E Urol 55:1419-1429
22. Abou YT, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S (2007) Active surveillance for selected patients with renal masses: Updated results with long-Term follow-up. Cancer 110:1010-1014
23. Rosales JC, Haramis G, Moreno J, Badani K, Benson MC, McKiernan J, Casazza C, Landman J (2010) Active surveillance for renal cortical neoplasms. J Urol 183:1698-1702
24. Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271-1279